University Of Michigan Health System Treats Its First Patients In Neuralstem’s … – PR Newswire (press release)
| PR Newswire (press release) ROCKVILLE, Md., Oct. 9, 2013 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR) announced that the University of Michigan Health System, in Ann Arbor, Michigan, treated its first two patients in the Phase II trial testing NSI-566 neural stem cells in … Neuralstem, Inc. (CUR): Neuralstem rises after announcing start of stem cell trialSeeking Alpha |
